Atlas-backed Generation Bio promises ‘druglike’ gene therapy – FierceBiotech
|
Atlas-backed Generation Bio promises 'druglike' gene therapy
FierceBiotech Backed by Atlas Ventures with a $25 million series A and headed by ex-Sobi CEO Geoff McDonough, Generation Bio says its lipid nanoparticle platform will allow it to offer the first genetic medicines that can be titrated to a particular dose—and … |
